US Will Have Reinforcement Advice for Most Americans 8 Months After Vaccination

[ad_1]

WASHINGTON — The Biden administration has decided that most Americans should have a coronavirus booster vaccine eight months after they’ve had their second vaccine, and may begin offering the third vaccines by mid to late September, according to administration officials familiar with the controversy.

Authorities plan to announce the decision as early as this week. Their goal is to let Americans who receive the Pfizer-BioNTech or Moderna vaccines know they will need additional protection against the Delta variant, which is causing caseloads to increase in much of the country. The new policy will depend on the Food and Drug Administration’s authorization for additional vaccines.

Officials said they expect recipients of the Johnson & Johnson vaccine, which is authorized as a single dose, will also need an additional dose. However, they are awaiting the results of that company’s two-dose clinical trial, expected later this month.

Initial supporters will likely go to nursing home residents and health workerswas followed by other older people near the front of the line when vaccines began late last year. Authorities envision giving people the same vaccine they originally received.

The decision came as the Biden administration struggled to regain control of a pandemic it claimed to have tamed a little over a month ago. President Biden had announced that the nation was reopening to normal life for the 4th of July holiday, but the wildfire spread of the Delta variant prevented that. COVID patients are again overwhelming hospitals in some states, and federal officials are worried about a jump in children hospitalized for the virus as the school year begins.

Biden administration officials have been analyzing the rising trend in Covid-19 cases for weeks, trying to understand whether the Delta variant can evade vaccines better than previous versions of the virus or whether the vaccines lose their effectiveness. According to some management experts, both could be true and exacerbate an epidemic the nation desperately hopes to be stopped.

Officials are particularly concerned by data from Israel that suggest that the Pfizer-BioNTech vaccine’s protection against serious illness has dropped significantly for seniors who get their second vaccination in January or February.

In some ways, Israel can be seen as a kind of template for the United States, as it vaccinates most of its population faster. Unlike the United States, it has used almost exclusively the Pfizer-BioNTech vaccine and has a nationalized healthcare system that allows it to follow patients systematically.

The latest data from Israel, published on the government’s website on Monday, shows that some experts have described the Pfizer vaccine’s efficacy as a sustained wear over time against both mild and asymptomatic Covid-19 infections in general and severe illness among the elderly. .

Reviewing the published data, vaccine expert Dr. “This shows a fairly steep decline in efficacy and efficacy against infection, but still a bit unclear on protection against serious disease,” said Peter J. Hotez. By Israel at the request of The New York Times.

Food and Drug Administration former chief scientist Dr. Jesse L. Goodman said the Israeli data suggest “worrying trends” that could indicate decreased vaccine efficacy. But he said he would like to see more details from Israel and, more importantly, data showing whether the US is moving in the same direction.

Federal officials said the booster program would likely follow the same scenario as the initial immunization program. The first shots for the general public in the United States were administered on December 14, days after the FDA authorized the Pfizer shot for emergency use. People started receiving the Moderna vaccine a week later.

While frontline healthcare workers and nursing home residents were among the first to be vaccinated nationwide, states followed their own plans for who else was eligible to be vaccinated during the first weeks and months of the vaccination campaign.

But almost everyone aged 65 and over is eligible to be vaccinated by the end of February, as are many police officers, teachers, grocery workers, and others at risk of exposure to the virus in the workplace.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *